Anti-ENO1 antibody-conjugated liposomes represent a new strategy for targeted therapy of gliomas. By specifically binding to the ENO1 antigen on the surface of glioma cells, this approach enhances the accumulation of drugs at the tumor site. This technology not only improves the therapeutic efficacy of the drugs but also reduces side effects on normal tissues. These targeted liposomes hold promise for research on gliomas.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-1162z | Mouse Anti-ENO1 Recombinant Antibody (clone 28F5) | WB, ELISA, IF, IHC | Mouse IgG1, κ |
FAMAB-0235-CN | Chicken Anti-ENO1 Recombinant Antibody (clone EnL2) | ELISA, WB, IF, FC | Chicken IgY |
VS3-FY498 | Recombinant Rabbit Anti-ENO1 Antibody (clone R09-9H5) | WB | Rabbit IgG |
VS3-WK1658 | Recombinant Mouse Anti-ENO1 Capture Antibody (clone 9F10) | ELISA | Mouse IgG2 |
VS3-WK1659 | Recombinant Mouse Anti-ENO1 Detection Antibody (clone 6H2) | ELISA | Mouse IgG1 |
There are currently no Customer reviews or questions for VS-1024-FY95. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.